Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Genetic and clinical predictors of treatment efficacy in depressive disorders].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 1 Jan 2000

Ivanets N N, Kinkulkina M A, Tikhonova Yu G, Izumina T A, Avdeeva T I, Morozov D I

Abstract excerpt

AIM: To study clinical and genetic characteristics that impact on the efficacy of pharmacotherapy of depressive disorders. MATERIAL AND METHODS: The study included 188 patients with unipolar depressive disorders of different genesis (psychogenic, endogenous and organic). A clinical-psychopathological method and depression psychometric scales were used. Serotonin transporter 5-HTTLPR and STin2 and dopamine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Tricyclic
Share to Depressive Disorder

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Dopamine Plasma Membrane Transport Proteins

Share to Psychiatric Status Rating Scales

Share to Psychometrics

Share to Selective Serotonin Reuptake Inhibitors

Share to Serotonin Plasma Membrane Transport Proteins

Source

Identifiers

PMID: 29171490
DOI: 10.17116/jnevro201711710155-64

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Genetic and clinical predictors of treatment efficacy in depressive disorders].PMID 29171490Read ↗

Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders.Semantic proximity Read ↗

[The genetics of depressive disorders].Semantic proximity Read ↗

[Association of several polymorphic loci of serotoninergic genes with unipolar depression].Semantic proximity Read ↗

The role of pharmacogenetics in the treatment of depression and anxiety disorders.Semantic proximity Read ↗

Associations of the serotonin transporter promoter polymorphism (5-HTTLPR) with bipolar disorder and treatment response: A systematic review and meta-analysis.Semantic proximity Read ↗

[Association of the 5HTTLPR/rs25531 Genetic Variant with Depression in a Cohort of Primary Care Patients].Semantic proximity Read ↗

Pharmacogenetic studies in depression: a proposal for methodologic guidelines.Semantic proximity Read ↗

Serotonin transporter gene polymorphisms and treatment-resistant depression.Semantic proximity Read ↗

Norepinephrine and serotonin transporter genes: impact on treatment response in depression.Semantic proximity Read ↗

[Treatment-resistant depression and antidepressant plasma level: Proposal of a pharmacogenetic-integrative algorithm from a case report].Semantic proximity Read ↗

The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.Semantic proximity Read ↗

The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.